Statins Do Not Reduce The Risk Of Colon Cancer

Statins Do Not Reduce The Risk Of Colon Cancer.
Statins don't belittle the danger of colorectal cancer, and may even burgeon the chances of developing precancerous polyps, unfledged research suggests weight. Statins are widely prescribed cholesterol-lowering drugs sold in a discrepancy of generic forms and stigmatize names, including Lipitor, Crestor and Zocor.

Yet, researchers stressed that the results are "not conclusive," and that masses taking statins to trim cholesterol and reduce their risk of heart attack should continue taking the drugs. "We found patients in this look at taking statins for more than three years tended to elaborate more premalignant colon lesions," said reading author Dr Monica Bertagnolli, chief of the division of surgical oncology at Brigham and Women's Hospital and a professor of surgery at Harvard Medical School. "This is an engaging verdict that needs to be followed up, but it should not animate alarm. No one should stop taking their statins vimax supplement in dubai.".

The weigh is to be presented Monday at the American Association for Cancer Research annual conference in Washington, DC, and it is also published online in the register Cancer Prevention Research. The data used in the assay was from an earlier clinical trial to determine if the cox-2 sedative celecoxib (Celebrex) could be used to prevent colon cancer.

That slang pain in the arse included 2035 people who were at high risk of colon cancer and had already been diagnosed with precancerous polyps, or adenomas. That study, published in 2006, found the celecoxib reduced the development of adenomas, but it also more than doubled the gamble of courage attack and other serious cardiac events.